NU 9056 is a selective cPLA2 (KAT5) histone acetyltransferase inhibitor. It has been shown to inhibit acetylation of proteins in prostate cancer cell lines. It block DNA damage response. It decreases proliferation of LNCap cells, and induces apoptosis by caspase activation.
10 mg/ml in DMSO
Soluble in DMSO.(supplied pre-dissolved in DMSO, 10 mg/ml).
Rated 5 out of
Ceffey et alCeffey et al. (PubMed ID 23056207) found that the Tip60 inhibitor, NU 9056, blocked cell proliferation in prostate cancer cell lines and induced apoptosis via activation of caspase 3 and caspase 9. -SCBT Publication Review
To place an order using RMB or to ship to mainland China, please visit www.scbio.cn